Showing 161 - 180 results of 5,248 for search '"Vascular endothelial growth factor"', query time: 0.22s Refine Results
  1. 161
  2. 162
  3. 163

    Intravitreal anti-vascular endothelial growth factor monotherapy in age-related macular degeneration with submacular hemorrhage by Maiko Maruyama-Inoue, Yoko Kitajima, Yasuo Yanagi, Tatsuya Inoue, Kazuaki Kadonosono

    Published 2023-04-01
    “…Although anti-vascular endothelial growth factor treatments were well-tolerated, for cases with large SMH at baseline, it should be considered that VH may occur during the monotherapy treatment process using IVA or IVBr, and that achieving good visual outcomes may be difficult in some cases.…”
    Get full text
    Article
  4. 164
  5. 165
  6. 166

    Molecular Targeting of Epidermal Growth Factor Receptor (EGFR) and Vascular Endothelial Growth Factor Receptor (VEGFR) by Nichole E. M. Kaufman, Simran Dhingra, Seetharama D. Jois, Maria da Graça H. Vicente

    Published 2021-02-01
    “…Epidermal growth factor receptor (EGFR) and vascular endothelial growth factor receptor (VEGFR) are two extensively studied membrane-bound receptor tyrosine kinase proteins that are frequently overexpressed in many cancers. …”
    Get full text
    Article
  7. 167

    Vascular endothelial growth factor as a response of denture bearing tissues on mechanical stress in diabetes mellitus by Radović Katarina, Brković Božidar, Ilić Jugoslav, Milić-Lemić Aleksandra, Jovanović Tamara, Jovanović Boris, Roganović Jelena

    Published 2023-01-01
    “…Introduction Vascular endothelial growth factor (VEGF) is signal molecule enrolled in diabetes mellitus type 2 (DM type 2) oral complications, but there are no studies showing the relation between VEGF and pressure caused by denture wearing in diabetic conditions. …”
    Get full text
    Article
  8. 168
  9. 169

    Predicting visual outcomes following anti-vascular endothelial growth factor treatment for diabetic macular edema by Vipin Rana, Aniruddha Agarwal, Atul Arora, Reema Bansal, Mohit Dogra, Sanjay Kumar Bhadada, Nirbhai Singh, Vishali Gupta

    Published 2024-01-01
    “…Purpose: To assess the utility of pre-defined imaging biomarkers on optical coherence tomography (OCT) and OCT angiography (OCTA) in patients with diabetic macular edema (DME) following anti-vascular endothelial growth factor (anti-VEGF) therapy in determining visual and anatomical outcomes. …”
    Get full text
    Article
  10. 170

    Vascular Endothelial Growth Factor Receptor 3 Controls Neural Stem Cell Activation in Mice and Humans by Jinah Han, Charles-Félix Calvo, Tae Hyuk Kang, Kasey L. Baker, June-Hee Park, Carlos Parras, Marine Levittas, Ulrick Birba, Laurence Pibouin-Fragner, Pascal Fragner, Kaya Bilguvar, Ronald S. Duman, Harri Nurmi, Kari Alitalo, Anne C. Eichmann, Jean-Léon Thomas

    Published 2015-02-01
    “…Here, we show that adult hippocampal NSCs express vascular endothelial growth factor receptor (VEGFR) 3 and its ligand VEGF-C, which activates quiescent NSCs to enter the cell cycle and generate progenitor cells. …”
    Get full text
    Article
  11. 171
  12. 172
  13. 173
  14. 174
  15. 175
  16. 176

    Systematic review of the risk of adverse outcomes associated with vascular endothelial growth factor inhibitors for the treatment of cancer. by Labib Imran Faruque, Meng Lin, Marisa Battistella, Natasha Wiebe, Tony Reiman, Brenda Hemmelgarn, Chandra Thomas, Marcello Tonelli

    Published 2014-01-01
    “…BACKGROUND: Anti-angiogenic therapy targeted at vascular endothelial growth factor (VEGF) is now used to treat several types of cancer. …”
    Get full text
    Article
  17. 177
  18. 178
  19. 179

    Expression of vascular endothelial growth factor is a clinically useful predictor for aggressive basal cell carcinoma by Jong Soon Choi, Dong Chan Lee, Hee Kyung Chang

    Published 2018-06-01
    “…Here we investigated the clinical utility of vascular endothelial growth factor (VEGF) as a predictive biomarker for aggressive BCC variants. …”
    Get full text
    Article
  20. 180

    Ebola virus disrupts the inner blood-retinal barrier by induction of vascular endothelial growth factor in pericytes. by Jiawang Gao, Zhengyuan Guo, Wei Li, Xiaowei Zhang, Xian-En Zhang, Zongqiang Cui

    Published 2023-01-01
    “…Cytokine screening revealed that EBO-VLPs stimulate pericytes to secrete vascular endothelial growth factor (VEGF) to cause iBRB breakdown. …”
    Get full text
    Article